Advanced glycation end products: role in pathology of diabetic cardiomyopathy (Q38081119)

28 August 2017

Advanced glycation end products: role in pathology of diabetic cardiomyopathy (English)

1 reference

advanced glycation end-product

28 August 2017

0 references

1 reference

ChEBI release 2020-05-28

ChEBI ID

84123

author name string

Vijaya Lakshmi Bodiga

series ordinal

1

1 reference

PubMed ID

23404649

28 August 2017

Sasidhar Reddy Eda

series ordinal

2

1 reference

PubMed ID

23404649

28 August 2017

Sreedhar Bodiga

series ordinal

3

1 reference

28 August 2017

1 January 2014

1 reference

28 August 2017

Heart Failure Reviews

1 reference

28 August 2017

19

1 reference

28 August 2017

49-63

1 reference

28 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-013-9374-y

28 August 2017

0 references

cites work

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Heart failure: the frequent, forgotten, and often fatal complication of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Role of diabetes in congestive heart failure: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Myocardial composition and function in diabetes. The effects of chronic insulin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Skin autofluorescence is a strong predictor of cardiac mortality in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Tobacco smoke is a source of toxic reactive glycation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Diabetes and advanced glycoxidation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Glycoxidation and lipoxidation in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Molecular biology of mammalian glucose transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Molecular cloning and characterization of an insulin-regulatable glucose transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Energy metabolism of the heart: from basic concepts to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Identification of fructose 3-phosphate in the lens of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

The Maillard hypothesis on aging: time to focus on DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

21 January 2018

12 December 2020

Conversion of methylglyoxal to acetol by Escherichia coli aldo-keto reductases

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Reduction of methylglyoxal in Escherichia coli K12 by an aldehyde reductase and alcohol dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Physiological role of mitochondrial Ca2+ transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Multiple Sp1 binding sites in the cardiac/slow twitch muscle sarcoplasmic reticulum Ca2+-ATPase gene promoter are required for expression in Sol8 muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

RAGE and modulation of ischemic injury in the diabetic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9374-Y

Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells

21 January 2018

1 reference

12 December 2020

Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus

1 reference

12 December 2020

Primary myocardial disease in the diabetic mouse. An ultrastructural study

1 reference

12 December 2020

The effect of advanced glycation end-product formation upon cell-matrix interactions

1 reference

12 December 2020

Monitoring of early and advanced glycation in relation to the occurrence of microvascular complications in children and adolescents with type 1 diabetes mellitus.

1 reference

12 December 2020

Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients

1 reference

12 December 2020

Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin

1 reference

12 December 2020

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease

1 reference

12 December 2020

Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats.

1 reference

12 December 2020

Formation of methylglyoxal-modified proteins in vitro and in vivo and their involvement in AGE-related processes.

1 reference

12 December 2020

New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids.

1 reference

12 December 2020

Atherogenesis and advanced glycation: promotion, progression, and prevention

1 reference

12 December 2020

Susceptibility of different rat tissues to non-enzymatic protein glycosylation in experimental diabetes.

1 reference

12 December 2020

Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

1 reference

12 December 2020

Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody

1 reference

12 December 2020

Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes

1 reference

12 December 2020

Advanced glycation end product accumulation in the cardiomyocytes of heart failure patients with and without diabetes.

1 reference

12 December 2020

Administration of AGEs in vivo induces extracellular matrix gene expression

1 reference

12 December 2020

Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes

1 reference

12 December 2020

Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy

1 reference

12 December 2020

Serum levels of advanced glycosylation end products in diabetic nephropathy

1 reference

12 December 2020

Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface

1 reference

12 December 2020

Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding

1 reference

12 December 2020

Effects of glucose intolerance on myocardial function and collagen-linked glycation

1 reference

12 December 2020

Influence of experimental diabetes on sarcoplasmic reticulum function in rat ventricular muscle

1 reference

12 December 2020

PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products

1 reference

12 December 2020

Glycation induces expansion of the molecular packing of collagen

1 reference

12 December 2020

Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy

1 reference

12 December 2020

Depressed cardiac sarcoplasmic reticular function from diabetic rats

1 reference

12 December 2020

Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").

1 reference

12 December 2020

Immunolocalization of GLUT-1 glucose transporter in rat skeletal muscle and in normal and hypoxic cardiac tissue

1 reference

12 December 2020

In-vitro carboxymethylation of low density lipoprotein alters its metabolism via the high-affinity receptor

1 reference

12 December 2020

Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats

1 reference

12 December 2020

Hemoglobin-AGE: a circulating marker of advanced glycosylation

1 reference

12 December 2020

Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy

1 reference

12 December 2020

Factors in human serum interfere with the measurement of advanced glycation endproducts

1 reference

12 December 2020

Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen

1 reference

12 December 2020

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

1 reference

12 December 2020

Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation.

1 reference

12 December 2020

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

12 December 2020

Diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase and ryanodine sensitive Ca(2+)Channel mRNA in streptozotocin-induced diabetic rat heart

1 reference

12 December 2020

Diabetic cardiomyopathy

1 reference

12 December 2020

Hyperglycemia results in an increase in myocardial interstitial glucose and glucose uptake during ischemia

1 reference

12 December 2020

TRC4149 a novel advanced glycation end product breaker improves hemodynamic status in diabetic spontaneously hypertensive rats

1 reference

12 December 2020

Identification of N epsilon- carboxymethyllysine as a degradation product of fructoselysine in glycated protein.

1 reference

12 December 2020

Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts

1 reference

12 December 2020

Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis

1 reference

12 December 2020

Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions

1 reference

12 December 2020

High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner

1 reference

12 December 2020

10.1007/S10741-013-9374-Y

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23404649